Gene doping, the use of gene therapy or genetic manipulation to enhance performance in horses, is prohibited by the IFHA and FEI due to concerns about horse welfare and the integrity of equestrian sport. Detection methods for gene doping are limited, making it difficult to test horses for this practice.
Gene therapy has the potential to treat equine diseases and injuries, but its illegal use in horses can lead to unfair competition and health risks. The IFHA and FEI prohibit gene doping, listing genes that could affect horse performance if manipulated. Testing for gene doping is challenging due to limited detection methods.
To combat gene doping in horse sports, strategies proposed include implementing regulatory frameworks, developing infrastructure for gene doping detection, creating sport-specific protocols, providing training for veterinarians and lab technicians, investing in advanced detection methods, fostering international collaboration, securing funding, and ensuring legal and ethical considerations. Regular monitoring and evaluation of anti-doping policies will be necessary to maintain credibility and integrity in equestrian sports.
